HR 3203 United States House · 117th Congress

To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

Summary
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2021
Committee Review
Floor Vote
President
Introduced May 13, 2021 Last action May 14, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
May 14, 2021
Committee
Referred to the Subcommittee on Health.
lower
May 13, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
May 13, 2021
Introduced
Introduced in House
lower
1 primary · 41 co-sponsors

Sponsors